Cases & Deals

Implanet completes €7 million rights issue

Clients Implanet SA

Jones Day advised Implanet SA, a medical technology company specializing in vertebral and knee-surgery implants, as well as SwissLife Banque Privée, in connection with the €7 million (US$7.5 million) rights issue of new and existing shares.